Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance

The unique ability to adapt and thrive in inhospitable, stressful tumor microenvironments (TME) also renders cancer cells resistant to traditional chemotherapeutic treatments and/or novel pharmaceuticals. Cancer cells exhibit extensive metabolic alterations involving hypoxia, accelerated glycolysis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Doris, Reiter, Russel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839844/
https://www.ncbi.nlm.nih.gov/pubmed/35163973
http://dx.doi.org/10.3390/molecules27030705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839844/
https://www.ncbi.nlm.nih.gov/pubmed/35163973
http://dx.doi.org/10.3390/molecules27030705

Ejemplares similares